speb/financial-data huggingface dataset:
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Payables: 14678290000.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 177585081.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 16433200000.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 12972630000.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 39670750000.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 17152160000.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 6558280000.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 17121740000.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 22549010000.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 12573560000.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1785860000.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 68220000.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Treasury Shares Number: 158000.00
SYRMA.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 6334040000.00
SYRMA.NS income_statement (quarterly, 2024-12-31) — Write Off: 21380000.00
SYRMA.NS income_statement (annual, 2025-03-31) — +Operating Expense: 6069700000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1644860000.00
SYRMA.NS income_statement (annual, 2025-03-31) — +Total Revenue: 37866910000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 9243610000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 15743860000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 15743860000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 14774610000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 14774610000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1989490000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1989490000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 10640940000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 10640940000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -159290000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -159290000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Amortization: 87260000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 87260000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 58280000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 58280000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 177875393.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 178302452.00
SYRMA.NS income_statement (annual, 2025-03-31) — Basic EPS: 9.55
SYRMA.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 3.67
SYRMA.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 783840000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 2410490000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 2410490000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -2451510000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Capital Expenditure Reported: -2451510000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 534260000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 534260000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 1780470000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1780470000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 808570000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 808570000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3421670000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3421670000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -266140000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 0.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 0.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 808570000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 808570000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 1824120000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -811590000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -58890000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Change In Payable: 3549000000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -5467790000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -934340000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 6130000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Common Stock: 1780470000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 1780470000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 17499640000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 17499640000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 10420000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Common Stock Payments: 0.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 621170000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 621170000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 29314720000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 6731300000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Current Assets: 29408920000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 29408920000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 86160000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 86160000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Current Debt: 5493150000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 5493150000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 5579310000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 5579310000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 22134970000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 22134970000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 54070000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 54070000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Depreciation: 750690000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 750690000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 750690000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 207500000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 750690000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 207500000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 178435924.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 178302452.00
SYRMA.NS income_statement (annual, 2025-03-31) — Diluted EPS: 9.52
SYRMA.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 3.67
SYRMA.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1698710000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 654370000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 1490000.00
SYRMA.NS income_statement (annual, 2025-03-31) — EBIT: 2955350000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — EBIT: 1090190000.00
SYRMA.NS income_statement (annual, 2025-03-31) — EBITDA: 3706040000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — EBITDA: 1297690000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 18590000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — End Cash Position: 808570000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 21970000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 21970000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -706980000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 859340000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 859340000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -686880000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -92950000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -167200000.00
SYRMA.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 391740000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Goodwill: 3221030000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 3221030000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 3459690000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 3459690000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 14933900000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 14933900000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 10640550000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 10640550000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Gross Profit: 8552190000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 2512310000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Interest Expense: 584600000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 156480000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 584600000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 156480000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Interest Income: 184620000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 184620000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -512850000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 167550000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Inventory: 8218660000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 8218660000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 23611390000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 23611390000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -1051520000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 80250000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 80250000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 60000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 60000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 10420000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 261550000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1382260000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1382260000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 448100000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 448100000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 618600000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 618600000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1066700000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1066700000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 261550000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -265290000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 60000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 60000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 5722320000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 5722320000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 748550000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 748550000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Minority Interests: -145790000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Minority Interests: -60160000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 10420000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Net Debt: 5303180000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 5303180000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -8460000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Net Income: 1698710000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Net Income: 654370000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1698710000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 654370000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1844500000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 714530000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1698710000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 654370000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1698710000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 654370000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 2370750000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1844500000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 714530000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Net Interest Income: -584600000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -156480000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 527500000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 329530000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -3740000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -584600000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -156480000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -135000000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 77750000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Net PPE: 8651060000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 8651060000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 725700000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 333270000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 14039950000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 14039950000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 31810000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 31810000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 22400000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 22400000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 139270000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 139270000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 152480000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 152480000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 158430000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 158430000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 3727420000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1297690000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Normalized Income: 1715344149.53
SYRMA.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 654370000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1764630000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Operating Income: 2482490000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Operating Income: 867450000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Operating Revenue: 37866910000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 9243610000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 178047112.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 178047112.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 10000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 16120000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 16120000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 435270000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 435270000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 45480000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 45480000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 238660000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 238660000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 381790000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 90000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 90000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 67490000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 67490000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 489220000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 142370000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 3408730000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 915680000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Other Payable: 416350000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 416350000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Other Properties: 504310000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 504310000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 2576230000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 2576230000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 2613100000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2613100000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Other Special Charges: -376110000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Payables: 16241960000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Payables: 16241960000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 351800000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 351800000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Pretax Income: 2370750000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 933710000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 19540000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -116000000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 6379970000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 6379970000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 29314720000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 6731300000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 750690000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 207500000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 16770000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 16770000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -265290000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: 0.00
SYRMA.NS income_statement (annual, 2025-03-31) — Research And Development: 25080000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 49830000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 49830000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 5022960000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 5022960000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 643500000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 725700000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 214180000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 605920000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Share Issued: 178158012.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 178158012.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 333270000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Special Income Charges: -21380000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 160790000.00
SYRMA.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 44650000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 17499640000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 17499640000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 14039950000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 14039950000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -4745850.47
SYRMA.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SYRMA.NS income_statement (annual, 2025-03-31) — Tax Provision: 526250000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 219180000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.22
SYRMA.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
SYRMA.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -606550000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Total Assets: 42046710000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 42046710000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 18118240000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 18118240000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Total Debt: 6646010000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 6646010000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 18248190000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 18248190000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Total Expenses: 35384420000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 8376160000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 23798520000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 23798520000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 12637790000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 12637790000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1663550000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1663550000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 43990000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 81750000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 81750000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -21380000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 252250000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -21380000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 252250000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 35680000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 35680000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Treasury Shares Number: 110900.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 110900.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Work In Process: 979350000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 979350000.00
SYRMA.NS balance_sheet (annual, 2025-03-31) — Working Capital: 7273950000.00
SYRMA.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 7273950000.00
SYRMA.NS income_statement (annual, 2025-03-31) — Write Off: 236700000.00
SYRMA.NS income_statement (quarterly, 2025-03-31) — Write Off: 215320000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1672790000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 9439800000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 178279570.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 2.79
SYRMA.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 7106630000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 205800000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 205800000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 178279570.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 2.79
SYRMA.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 497400000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — EBIT: 820790000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — EBITDA: 1026590000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 2333170000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 149320000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 149320000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -1800000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Net Income: 497400000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 497400000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 499200000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 497400000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 497400000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 499200000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -149320000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -149320000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1026590000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 497400000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Operating Income: 660380000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 9439800000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 69330000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 963160000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 671470000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 7106630000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 205800000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 172270000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
SYRMA.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 8779420000.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
SYRMA.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1794580000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 11458870000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 18081530000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 18965620000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 469930000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 186220930.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 3.44
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 495830000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1923090000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 3113490000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 9204070000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 1923090000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 28088980000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 770390000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 8730410000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 39034300000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 91320000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 2297880000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2389200000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 21673960000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 46260000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 218490000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 218490000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 186763848.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 3.43
SYRMA.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 640600000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — EBIT: 1021310000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — EBITDA: 1239800000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 3221040000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 3419430000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 8791150000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 2728460000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 126310000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 126310000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 8795100000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 30908690000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 469930000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 404510000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 521830000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 926340000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 783680000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -22810000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Net Income: 640600000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 640600000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 663410000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 640600000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 640600000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 663410000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -126310000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -126310000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 8791150000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 24669550000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 23290000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 124480000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 181870000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1239800000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 640600000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Operating Income: 933880000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 11458870000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 192309763.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2069510000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 323850000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 26165890000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 198390000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 189620000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 69790000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 87440000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1061450000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 8020760000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 6090580000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Payables: 18259980000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 895000000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 8730410000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 218490000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 192464163.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 28088980000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 24669550000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 231590000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.26
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 52097120000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 28610810000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 3315540000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 28872660000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 10524990000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 23224460000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 13062820000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1550500000.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 178450000.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
SYRMA.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 154400.00
SYRMA.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 17360340000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 2077110000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 12641800000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 192844278.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 5.33
SYRMA.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 9173520000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 202830000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 202830000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 192844278.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 5.33
SYRMA.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1027860000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — EBIT: 1460300000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — EBITDA: 1663130000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 3468280000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 76820000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 76820000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -75280000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Net Income: 1027860000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1027860000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1103140000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1027860000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1027860000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1103140000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -76820000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -76820000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1696960000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 1054834893.89
SYRMA.NS income_statement (quarterly, 2025-12-31) — Operating Income: 1391170000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 12641800000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 102960000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1318020000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 1383480000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 9173520000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 202830000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -33830000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -6855106.11
SYRMA.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 280340000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.20
SYRMA.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 11250630000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -33830000.00
SYRMA.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -33830000.00
SYRMA.NS income_statement (annual, 2026-03-31) — +Operating Expense: 7720520000.00
SYRMA.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 2267110000.00
SYRMA.NS income_statement (annual, 2026-03-31) — +Total Revenue: 48190590000.00
SYRMA.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 14650120000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 19585650000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 19585650000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 18407770000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 18407770000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 498090000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 498090000.00
SYRMA.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 191293006.00
SYRMA.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 5.29
SYRMA.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 808570000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1917590000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Capital Expenditure Reported: -1917590000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 467750000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 467750000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 1926250000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1926250000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1922810000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1922810000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 10093680000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 10093680000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -288530000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -1652880000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -1184580000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -143590000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Change In Payable: 3754680000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -2634740000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -1888520000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 1054560000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Common Stock: 1926250000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1926250000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 28621880000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 28621880000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 9749490000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Common Stock Payments: -98530000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 675490000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 675490000.00
SYRMA.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 35866050000.00
SYRMA.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 10855490000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Current Assets: 41496860000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 41496860000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 83650000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 83650000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Current Debt: 3138230000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 3138230000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 3221880000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 3221880000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 24408570000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 24408570000.00
SYRMA.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 64710000.00
SYRMA.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 64710000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Depreciation: 841090000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 841090000.00
SYRMA.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 841090000.00
SYRMA.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 213970000.00
SYRMA.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 841090000.00
SYRMA.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 213970000.00
SYRMA.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 191655303.00
SYRMA.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 5.28
SYRMA.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 3177800000.00
SYRMA.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1011940000.00
SYRMA.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 0.00
SYRMA.NS income_statement (annual, 2026-03-31) — EBIT: 4936360000.00
SYRMA.NS income_statement (quarterly, 2026-03-31) — EBIT: 1633960000.00
SYRMA.NS income_statement (annual, 2026-03-31) — EBITDA: 5777450000.00